DSP-1053 is primarily investigated for its potential therapeutic applications in the field of neuroscience. It is being studied for its role in modulating serotonin receptors, which could make it a candidate for treating psychiatric disorders such as depression, anxiety, and schizophrenia. The compound’s ability to influence serotonin pathways may help regulate mood and cognitive functions, offering a new approach to managing these conditions. Additionally, DSP-1053 is explored for its potential in addressing neurodegenerative diseases by targeting specific receptors involved in brain health and function. Its application in clinical trials aims to evaluate its efficacy and safety as a novel treatment option in mental health and neurological research.